Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice

International Journal of Cancer

Volumn 119, Issue 1, 2006, Pages 99-107

  Kholodnyuk, Irina D ^a,b,c   Kozireva, Svetlana ^b   Kost Alimova, Maria ^a   Kashuba, Vladimir ^a   Klein, George ^a   Imreh, Stefan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b A Kirchenstein Institute of Microbiology and Virology   (Latvia)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Human chromosome 3 genes; Microcell hybrid; SCID tumours

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; FRAGILE HISTIDINE TRIAD PROTEIN; LACTOFERRIN; MESSENGER RNA; SOLUTE CARRIER FAMILY 38 MEMBER 3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CHROMOSOMAL INSTABILITY; CHROMOSOME 3P; CONTROLLED STUDY; DNA SEQUENCE; DRR1 GENE; FIBROSARCOMA; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LTF GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; SLC38A3 GENE; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; DOWN-REGULATION; FIBROSARCOMA; GENES, TUMOR SUPPRESSOR; HUMANS; LACTOFERRIN; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, SCID; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM-CALCIUM EXCHANGER;

EID: 33646519908     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21794     Document Type: Article

References (58)

1. Harris H, Miller OJ, Klein G, Worst P, Tachibana T. Suppression of malignancy by cell fusion. Nature 1969;223:363-8.
2. Klein G, Bregula U, Wiener F, Harris H. The analysis of malignancy by cell fusion. I. Hybrids between tumour cells and L cell derivatives. J Cell Sci 1971;8:659-72.
3. Stanbridge EJ, Flandermeyer RR, Daniels DW, Nelson-Rees WA. Specific chromosome loss associated with the expression of tumorigenicity inhuman cell hybrids. Somat Cell Genet 1981;7:699-712.
4. Anderson MJ, Stanbridge EJ. Tumor suppressor genes studied by cell hybridization and chromosome transfer. Faseb J 1993;7:826-33.
5. Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumours and the search for suppressor genes. Adv Cancer Res 1997;71:27-92.
6. Zabarovsky ER, Lerman MI, Minna JD. Tumour suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002;21:6915-35.
7. Imreh S, Klein G, Zabarovsky ER. Search for unknown tumour-antagonizing genes. Gene Chromosome Cane 2003;38:307-21.
8. Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumour suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumour Suppressor Gene Consortium. Cancer Res 2000;60:6116-33.
9. Huebner K, Druck T, Siprashvili Z, Croce CM, Kovatich A, McCue PA. The role of deletions at the FRA3B/FHIT locus in carcinogenesis. Recent Results Cancer Res 1998;154:200-15.
10. Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y. Molecular cloning of a candidate tumour suppressor gene, DLCl, from chromosome 3p21.3. Cancer Res 1999;59:1966-72.
11. Imreh S, Kholodnyuk I, Allikmetts R, Stanbridge EJ, Zabarovsky ER, Klein G. Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice. Gene Chromosome Cane 1994;11:237-45.
12. Kholodnyuk ID, Kost-Alimova M, Kashuba VI, Gizatulin R, Szeles A, Stanbridge E, Zabarovsky ER., Klein G, Imreh S. A 3p21.3 Region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumour growth in SCID mice. Gene Chromosome Cane 1997;18:200-11.
13. Kholodnyuk I, Kost-Alimova M, Yang Y, Kiss H, Fedorova L, Klein G, Imreh S. The microcell hybrid based "elimination test" identifies a 1-Mb putative tumour suppressor region at 3p22.2-p22.1 centromeric to the homozygous deletion region detected in lung cancer. Gene Chromosome Cane 2002;34:341-4.
14. Kholodnyuk I, Szeles A, Yang Y, Klein G, Imreh S. Inactivation of the Human Fragile Histidine Triad Gene at 3pl4.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumours. Cancer Res 2000;60:7119-25.
15. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mod M, McCue P, Druck T, Croce CM, Huebner K. The FHIT gene, spanning the chromosome 3pl4.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-97.
16. Huebner K. Tumour suppressors on 3p: a neoclassic quartet. Proc Natl Acad Sci USA 2001;98:14763-5.
17. Pekarsky Y, Zanesi N, Palamarchuk A, Huebner K, Croce CM. FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol 2002;3:748-54.
18. Petursdottir TE, Thorsteinsdottir U, Jonasson JG, Moller PH, Huiping C, Bjornsson J, Egilsson V, Imreh S, Ingvarsson S. Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues. Gene Chromosome Canc 2004;41:232-42.
19. Maitra A, Wistuba II, Washington C, Virmani AK, Ashfaq R, Milchgrub S, Gazdar AF, Minna JD. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol 2001;159:119-30.
20. Saxon PJ, Stanbridge EJ. Transfer and selective retention of single specific human chromosomes via microcell-mediated chromosome transfer. Methods Enzymol 1987;151:313-25.
21. Cuthbert AP, Trott DA, Ekong S, Jezzard NL, England M, Themis M, Todd CM, Newbold RF. Construction and characterization of a highly stable humna:rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenet. Cell Genet 1995;71:68-76.
22. Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Emberg I, Klein G. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael. J Virol 1989;63:3135-41.
23. Mitelman F. Recurrent chromosome aberrations in cancer. Mutat Res 2000;462:247-53.
24. Todd MC, Xiang RH, Garcia DK, Kerbacher KE, Moore SL, Hensel CH, Liu P, Siciliano MJ, Kok K, van den Berg A, Veldhuis P, Buys CH, et al. An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumour growth in vivo. Oncogene 1996;13:2387-96.
25. Xiang R, Davalos AR, Hensel CH, Zhou XJ, Tse C, Naylor SL. Semaphorin 3F gene from human 3p21.3 suppresses tumour formation in nude mice. Cancer Res 2002;62:2637-43.
26. Chaudhry FA, Reimer RJ, Krizaj D, Barber D, Storm-Mathisen J, Copenhagen DR, Edwards RH. Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cell 1999;99:769-80.
27. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000;25:315-9.
28. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001;93:691-9.
29. Agathanggelou A, Cooper WN, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005;65:3497-508.
30. Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001;61:3877-81.
31. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, et al. The candidate tumour suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumourigenesis. Proc Natl Acad Sci USA 2001;98:7504-9.
32. Diaz R, Lopez-Barcons L, Ann D, Garcia-Espana A, Yoon A, Matthews J, Mangues R, Perez-Soler R, Pellicer A. Complex effects of Ras proto-oncogenes in tumorigenesis. Carcinogenesis 2004;25:535-9.
33. Yamato T, Orikasa K, Fukushige S, Orikasa S, Horii A. Isolation and characterization of the novel gene, TU3A, in a commonly deleted region on 3pl4.3->p14.2 in renal cell carcinoma. Cytogenet Cell Genet 1999;87:291-5.
34. Wang L, Darling J, Zhang JS, Liu W, Qian J, Bostwick D, Hartmann L, Jenkins R, Bardenhauer W, Schutte J, Opalka B, Smith DI. Loss of expression of the DRR 1 gene at chromosomal segment 3p21.1 in renal cell carcinoma. Gene Chromosome Cane 2000;27:1-10.
35. Bezault J, Bhimani R, Wiprovnick J, Furmanski P. Human lactoferrin inhibits growth of solid tumours and development of experimental metastases in mice. Cancer Res 1994;54:2310-2.
36. Siebert PD, Huang BC. Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumour-derived cell lines. Proc Natl Acad Sci USA 1997;94:2198-203.
37. Yang Y, Kost-Alimova M, Ingvarsson S, Qianhui Q, Kiss H, Szeles A, Kholodnyuk I, Cuthbert A, Klein G, Imreh S. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumour growth in severe combined immunodeficient (SCID) mice. Proc Natl Acad Sci USA 2001;98:1136-41.
38. Yang Y, Li J, Szeles A, Imreh MP, Kost-Alimova M, Kiss H, Kholodnyuk I, Fedorova L, Darai E, Klein G, Imreh S. Consistent downregulation of human lactoferrin gene, in the common eliminated region 1 on 3p21.3, following tumour growth in severe combined immunodeficient (SCID) mice. Cancer Lett 2003;191:155-64.
39. Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003;300:455.
40. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003;300:489-92.
41. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-53.
42. El-Osta A. DNMT cooperativity - the developing links between methylation, chromatin structure and cancer. Bio Essays 2003;25:1071-84.
43. Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nature Reviews 2003;3:685-694.
44. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005;24:2899-908.
45. Eisenman RN. The Max network: coordinated transcriptional regulation of cell growth and proliferation. Harvey Lec 2000;96:1-32.
46. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB. Analysis of genomic targets reveals complex functions of MYC. Nature Reviews 2004;4:562-568.
47. Sacchi CM, Schiaffonati L. The effect of etoposide (VP-16) on mouse L fibroblasts: modulation of stress response, growth and apoptosis genes. Anticancer Res 1996;16:3659-64.
48. Kiss H, Yang Y, Kiss C, Andersson K, Klein G, Imreh S, Dumanski JP. The transcriptional map of the common eliminated region (C3CER1) in 3p21.3. Eur J Human Genetics 2002a;10:52-61.
49. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. AJP - Regulatory, integrative and comparative physiology. 2002;283:R7-28.
50. Fan P, Kyaw H, Su K, Zeng Z, Augustus M, Carter KC, Li Y. Cloning and characterization of a novel human chemokine receptor. Biochem. Biophys Res Commun 1998;243:264-8.
51. Kiss H, Darai E, Kiss C, Kost-Alimova M, Klein G, Dumanski JP, Imreh S. Comparative human/murine sequence analysis of the common eliminated region 1 from human 3p21.3. Mamm Genome 2002b;13:646-55.
52. Handt O, Sutherland GR, Richards RI. Fragile sites and minisatellite repeat instability. Mol Genet Metab 2000;70:99-105.
53. Richards RI. Fragile and unstable chromosomes in cancer:causes and consequences. Trends Genet 2001;17;339-45.
54. Kost-Alimova M, Kiss H, Fedorova L, Yang Y, Dumanski JP, Klein G, Imreh S. Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3. Proc Natl Acad Sci USA 2003;100:6622-7.
55. Kok K, Van den Berg A, Veldhuis PM, Franke M, Terpstra P, Buys CH. The genomic structure of the human UBE1L gene. Gene Expr 1995;4:163-75.
56. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW, III, Garner HR, McKay B, Latif F, Lerman MI, Lam S, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000;60:1949-60.
57. Angeloni D, Lerman MI. Human lung cancer: cancer-causing genes and environmental factors. In: Peters GA, Peters BJ, eds. Sourcebook on Asbestos Diseases. Philadelphia: LexisNexis Press, 2001.169-209.
58. Braga E, Sentchenko V, Bazov I, Loginov W, Liu J, Debabov V, Ermilova V, Kazubskaya T, Garkavtseva R, Mazurenko N, Kisseljov F, Lerman MI, et al. Critical tumour-suppressor gene regions on chromosome 3P in major human epithelial malignancies:allelotyping and quantitative real-time PCR. Int J Cancer 2002;100:534-41.